Nanomedicine

OCT 6, 2026 · JOURNAL ARTICLE

Evolving skin cancer therapeutics: molecular and genetic drivers, immunotherapy challenges, and advances in nanogel-based nanomedicine

Nanomedicine

Skin cancer is among the most common malignancies worldwide, with a rising global incidence. Cancer develops through complex molecular and genetic changes. Current treatments, such

SEP 10, 2026 · JOURNAL ARTICLE

CRISPR-Cas9‑based lipid nanocarriers for advanced therapy of urinary bladder cancer

Nanomedicine

This is a narrative review of CRISPR-Cas9 delivery concepts for bladder cancer therapy with no original experimental data, clinical trial results, or comparative evidence.

SEP 9, 2026 · JOURNAL ARTICLE

Mucus-penetrating nanocarriers for the enhanced oral delivery of antibody drugs

Nanomedicine

This is a narrative review article examining design principles for mucus-penetrating nanocarriers to enhance oral antibody delivery, raising questions about preclinical advances rather than reporting primary experimental results or clinical evidence.

SEP 1, 2026 · JOURNAL ARTICLE

Insights into the use of artificial intelligence in the drug discovery and delivery of nanosystems for the treatment of infectious diseases and neoplasms

Nanomedicine

A narrative review synthesizing AI applications across drug discovery, nanosystems delivery, and disease treatment; descriptive and exploratory rather than reporting original empirical results or clinical outcomes.